2018 Speakers Included:
Steve Byrn, PhD
Charles B. Jordan Professor of Medicinal Chemistry, Purdue University
Viral Kansara, PhD
Investigator and Lab Head - Ocular PK and Drug Delivery, Novartis
Luis Santos, PhD
Scientist II, Dosage Form Design & Development (DFDD), MedImmune
Niren Murthy, PhD
Professor, Bioengineering, UC Berkley
Indrajit Ghosh, PhD
Associate Director, Global Pharmaceutical Development, Celgene
David Cipolla, PhD
Vice President of Research, Insmed
Nima Roohpour, PhD
Principal Innovation Scientist, GlaxoSmithKline
Pavel Farkas, PhD
Senior Director , Biopharmaceutics/Clinical Development, Teva
Piotr Grodzinski, PhD
Director, NCI Office of Cancer Nanotechnology Research, NCI / NIH
Dhaval Patel, PhD
Senior Research Investigator I-Research Investigator, Bristol Myers Squibb
Bob Prud'Homme, PhD
Professor and Director Program in Engineering Biology, Princeton University
Boris Shekunov, PhD
Director and Senior Principal Scientist, Shire
Tamara Minko, PhD
Distinguished Professor and Chair, Rutgers University
Gaurav Tolia, PhD
Senior Lead Scientist, Topical and Transdermal Product Development, Mylan
Grace Okoh, PhD
Associate Principal Scientist, Merck & Co
J. Blair West, PhD
Chief Scientific Officer, Bioduro
Lilly Roy, PhD
Scientist II, Vertex Pharmaceuticals
Sree Nadkarni, PhD
Senior Director, Pharma Development, Biotie Therapies
Carol Thomson, PhD
Chief Executive Officer, BDD
Mikolaj Milewski, PhD
Principal Scientist, Oral Biopharmaceutics/Drug Absorption, Merck & Co
2017 Speakers Included:
Ketan Mehta PhD
President & CEO, Tris Pharma
Linda Lohr, PhD.
Senior Director, Portfolio Strategy, Pfizer, Inc.
Adam Procopio, PhD.
Senior Principal Scientist, Drug Product Additive Manufacturing (3D Printing) Lead, Merck & Co.
Esmaiel Jabbari, PhD.
Professor of Chemical Engineering University of South Carolina
Bonnie Fendrock, MBA
CEO and Co-Founder, Cyta Therapeutics, Inc.
Rakesh Dixit, PhD
Vice President, R&D Head Biologics Safety Assessment, MedImmune
Christopher A. Rhodes, PhD.
President & CEO, Drug Delivery Experts
Liz Proos, PhD.
Director, Formulation Development, Microchips Biotech, Inc.
Marian Gindy, PhD
Director, Sterile Formulation Sciences, Merck
Molly Story, PhD.
Head, Global Usability Engineering and Risk Management, Medical Device Development Unit, Sanofi
Amit Joshi, PhD.
Senior Manager, Advanced Sourcing & Innovation, Johnson & Johnson
Vincent Jannin, PhD.
Research Director, Pharmaceuticals, Gattefossé
Abizer Harianawala, PhD
Senior Director - Product Development and Technical Operations, TARIS Biomedical
Shaker Mousa, PhD
Chairman & Executive Vice President, The Pharmaceutical Research Institute
Jigar Patel, PhD
Director Technology Innovation, Roche Diagnostics
Laszlo Otvos, PhD.
Adjunct Professor, Semmelweis Medical School
Tian Wu, PhD.
Senior Scientist, Drug Product Technology, Amgen
Susan Rosenbaum, JD.
Founder, Chairman & Chief Executive Officer, Lauren Sciences LLC
Robert Prud'homme, PhD.
Professor, Department of Chemical & Biological Engineering, Princeton University
Les Miranda, PhD
Director Research, Hybrid Modality Engineering, Structural Biology, & Molecular Modeling, Therapeutic Discovery, Amgen
Raghu Raghavan, PhD
President and Co-Founder, Therataxis, LLC
John Paderi, PhD.
Founder, Director Research & Development, Symic Bio
Viral Kansara, PhD.
Investigator and Head of Ocular Pharmacology and Drug Delivery Laboratory, Novartis
Sonia Bedi, PhD
Principal Scientist, Biopharm Product Sciences, Biopharm R&D, GlaxoSmithKline
Joseph Della Rocca
Senior Scientist, Merck & Co.
Jaymin Shah, PhD.
Senior Research Fellow and Team Leader, Pharmaceutical Sciences, Pfizer, Inc. (Pending Confirmation)
Michael Wagner, PhD.
Head of Insulins & Peptides, Diabetes Division, Sanofi
Rob Harris, PhD.
Chief Technical Officer, Juniper Pharma Services
Anthony Qu, PhD
Vice President, Drug Product Development, Halo Pharmaceuticals
Scott Peterson, PhD.
Executive Director, Corporate Development, Intarcia Therapeutics
Jay Lakshman, PhD
Project Leader and Technology Platform Leader, Novartis
Zhen Yang, PhD.
Associate Principal Scientist, Biopharmaceutics & Specialty Dosage Form, Merck & Co.
Grégoire Schwach, PhD.
Head of Drug Delivery, F. Hoffmann-La Roche
Brad Garcia, PhD.
Strategic Technology Commercialization Leader, Roche Sequencing
Stephen Tindal, BSc.
Director, Science & Technology, Catalent Pharma Solutions
Gaurav Tolia, PhD.
Senior Research Scientist, Mylan Inc.
Rubi Burlage, PhD
Director, Formulation Sciences, Merck & Co.
Irina Kadiyala, PhD.
Senior Scientist, Delivery Systems, Vertex Pharmaceuticals
John Morrison, PhD.
Senior Research Investigator, Bristol-Myers Squibb (Invited)
Alfred Berchielli, PhD.
Senior Principal Scientist, Drug Product Design, Pfizer, Inc.
David Schaffer, PhD.
Professor, Chemical and Biomolecular Engineering, University of California, Berkeley
Gaurav Bhardwaj, PhD.
Head of the Institute for Protein Design, Professor of Biochemistry, University of Washington
Sree Nadkarni, PhD.
Senior Director, Pharmaceutical Dev. (CMC) Biotie Therapies, Inc. (Acorda Therapeutics)
Mehuli Kulkarni, PhD
Consultant Chemist, Eli Lilly